Jitterbit Named Leader for 2026 Data Integration Data Quadrant Report by Info-Tech Research Group Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting
Targeted, precision-tuned agonist of IL-2 receptor selectively expands regulatory T cells SEATTLE, Dec. 12, 2022…
ORYZON Presents Final Data From Phase IIa ALICE Trial in Unfit AML Patients with First-line Treatment of Iadademstat and Azacitidine in Oral Presentation at ASH-2022
Robust, rapid and durable efficacy – ORR 81%, of which 64% are CR/CRi 68% of…
Poloniex Adds Cross-Margin Mode for Spot Trading
Panama City, Panama–(Newsfile Corp. – December 12, 2022) – Poloniex, a global crypto exchange, is…
Now Newbies Can Sell Bitcoin in Dubai and Get Cash at SBID Crypto OTC
Dubai, United Arab Emirates–(Newsfile Corp. – December 12, 2022) – Selling bitcoin in Dubai is…
Texas First Rentals, a Division of HOLT, Acquires Rental One, a Construction Equipment Rental Company
SAN ANTONIO–(BUSINESS WIRE)–Texas First Rentals®, a division of HOLT, announced today that it has acquired…
Predicta’s AI Explores a New Question: Does the Elon Brand Hurt Tesla?
DALLAS–(BUSINESS WIRE)–It may be the talk of the town, but it’s nothing new. For years,…
New Study from University Hospitals Shows Time-Saving Advantage of ArthroFree™ Wireless Arthroscopic Camera
The study is part of a broader collaboration between Lazurite and University Hospitals (UH) Ventures…
FOX Business Network to Launch New Programming in January
Bloomberg Television’s Taylor Riggs Joins FBN As Co-Anchor of “The Big Money Show” Alongside Brian…
NTT DATA Research Reveals Shift from Survival to Resilience and Growth
Executives remain optimistic in the face of continued macroeconomic and global disruptions PLANO, Texas–(BUSINESS WIRE)–NTT…
DeciBio Consulting Adds Steve Beuchaw as a Partner, Establishing a New York Presence
LOS ANGELES–(BUSINESS WIRE)–#Duke–DeciBio Consulting, LLC, a precision medicine-focused strategic consulting and market intelligence firm, has…
Infineon Again Listed in Dow Jones Sustainability Index
MUNICH–(BUSINESS WIRE)–Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is one of the most sustainable…
IDC FutureScape: Top 10 Predictions for the Future of Digital Infrastructure
NEEDHAM, Mass.–(BUSINESS WIRE)–#DigitalInfrastructure–International Data Corporation’s (IDC) highlights key, impactful trends for the future of digital…
University of Phoenix Announces Agreement With Central Wyoming College
Academic agreement supports pathways for students from community college to higher degrees at the University…
DeepSig Ranked Number 339 Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™
Attributes 409% Revenue Growth to DeepSig’s uniquely talented team and continued support from partners and…
Mydecine Innovations Group Closes Sale of Its Wholly-Owned Subsidiary, Mindleap Health Inc.
DENVER, Dec. 12, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group Inc. (“Mydecine” or the “Company”)…
Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma
Data showcase the potential of glofitamab and Lunsumio to address diverse patient needs Data presented…
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022
– 100% of patients treated with bomedemstat for ≥24 weeks (n=62 as of October 18,…
Elixirgen Therapeutics Presents New Clinical Data Demonstrating Ex Vivo Telomere Elongation with EXG-34217 in Dyskeratosis Congenita at the 64th ASH Annual Meeting
Treatment with EXG-34217 increased the telomere length of CD34+ cells by 1.24-fold ex vivo Telomere…
Optimize your time and investment by downloading a networking info app for the 41st Annual JP Morgan Health Care Conference
VANCOUVER, British Columbia and WASHINGTON, Dec. 12, 2022 (GLOBE NEWSWIRE) — Today, Novateur Ventures, a…
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
Updated analyses report on progression-free survival, minimal residual disease negativity, overall response and overall survival…